AI Article Synopsis

Article Abstract

Point-of-care testing (POCT) for D-dimer is an alternative to -laboratory testing for the exclusion of venous thromboembolism (VTE). This critical review by the "CEC et biologie délocalisée" working group of the "Société Française de Thrombose et d'Hémostase" (French Society of -Thrombosis and Haemostasis) aims to present the characteristics of six POCT D-dimer assays available in France in 2023. The article highlights the need to define VTE -exclusion thresholds specific to each technique and validated by clinical studies. There is insufficient data to validate the use of cut off suggested by manufacturers, and age-adjusted thresholds. The article discusses the role of laboratories in justifying and prescribing POCT D-dimer, according to objective criteria, such as the availability and turnaround time of classical laboratory tests. They should also encourage rational prescribing, limited to patients with low risk of venous thromboembolism, following an assessment of clinical probability according to national and international guidelines.

Download full-text PDF

Source
http://dx.doi.org/10.1684/abc.2023.1839DOI Listing

Publication Analysis

Top Keywords

venous thromboembolism
12
poct d-dimer
12
exclusion venous
8
[point-of-care testing
4
d-dimer
4
testing d-dimer
4
d-dimer exclusion
4
thromboembolism critical
4
critical analysis]
4
analysis] point-of-care
4

Similar Publications

Incidence of venous thromboembolism in fracture below the knee with and without chemical thromboprophylaxis: a systematic review and meta-analysis.

Arch Orthop Trauma Surg

December 2024

Medical City UNT/TCU Orthopaedic Surgery Residency Program Director, 3325 Medpark Dr, Denton, TX, 76210, USA.

Introduction: Low rates of venous thromboembolism (VTE) have been found in patients with isolated orthopaedic trauma below the knee. Many surgeons routinely provide chemical thromboprophylaxis in these injuries, however. This is not without inherent risks, and this remains a controversial topic in perioperative care in orthopaedic trauma.

View Article and Find Full Text PDF

Objective: To develop and validate a nomogram for predicting non-retrieval of the short-term retrievable inferior vena cava (IVC) filters.

Methods: In this study, univariate and multivariate logistic regression analyses were performed to identify predictive factors of short-term retrievable filter (Aegisy or OptEase) non-retrieval, and a nomogram was then established based on these factors. The nomogram was created based on data from a training cohort and validated based on data from a validation cohort.

View Article and Find Full Text PDF

Unlocking the potential of neuromuscular electrical stimulation: achieving physical activity benefits for all abilities.

Front Sports Act Living

November 2024

Integrative Orthopedic Laboratory, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Neuromuscular Electrical Stimulation (NMES) uses electrical impulses to induce muscle contractions, providing benefits in rehabilitation, muscle activation, and as an adjunct to exercise, particularly for individuals experiencing immobilization or physical disability. NMES technology has significantly progressed, with advancements in device development and a deeper understanding of treatment parameters, such as frequency, intensity, and pulse duration. These improvements have expanded NMES applications beyond rehabilitation to include enhanced post-exercise recovery, improved blood glucose uptake, and increased lower limb venous return, potentially reducing thrombotic risks.

View Article and Find Full Text PDF

 Venous thromboembolism (VTE) is still a major challenge after major orthopaedic surgery, including total knee replacement (TKR). The aim of this study was to estimate the risk of VTE with aspirin-only pharmacologic prophylaxis following primary TKR surgery versus direct oral anticoagulant (DOAC).  The study included 476 patients who underwent primary TKR from 2016 to 2020.

View Article and Find Full Text PDF

Background: Venous thromboembolic events (VTEs) are the second-leading cause of death in cancer patients, with an incidence of 5%-17% in lymphoma patients, particularly higher in those with non-Hodgkin lymphoma (NHL). Existing risk assessment models (RAMs) like the Khorana and ThroLy scores have limitations and are inadequately validated for NHL patients. Coagulation markers such as D-dimer, thrombin-antithrombin complex (TAT), and thrombomodulin (TM) show a potential predictive value for cancer-associated VTE but lack extensive research in NHL.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!